Home › Companies › PACIFIC BIOSCIENCES OF CALIFORNIA INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s Form 8-K, filed June 6, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 4, 2025: 6 items on PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s Form 8-K, filed June 6, 2025: 3 elected · 3 approved.
Significant dissent: 1 say-on-pay vote (60.8% support); 1 equity or compensation plan (33.8% against).
Notable dissent: 1 director (19.2% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore PACIFIC BIOSCIENCES OF CALIFORNIA INC. in the interactive database Compare manager voting policies
These tallies are PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 6, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: William Ericson | 104,132,466 | 24,793,642 | 809,854 | -- | 56,387,161 | 81% | Elected | — |
| Elect Director: Kathy Ordoñez | 126,729,273 | 2,137,971 | 868,718 | -- | 56,387,161 | 98% | Elected | — |
| Elect Director: Christopher M. Smith | 126,830,161 | 2,076,866 | 828,935 | -- | 56,387,161 | 98% | Elected | — |
| 2. Ratification of the Appointment of Independent Registered Public Accounting Firm | 162,154,849 | 22,599,739 | 1,368,535 | -- | -- | 88% | Approved | — |
| 3. Advisory Vote on Approval of Named Executive Officer Compensation | 78,367,531 | 50,498,020 | 870,411 | -- | 56,387,161 | 61% | Approved | — |
| 4. Approval of Amendment to the 2020 Equity Incentive Plan | 85,355,382 | 43,563,859 | 816,721 | -- | 56,387,161 | 66% | Approved | — |
Source: PACIFIC BIOSCIENCES OF CALIFORNIA INC., Form 8-K, filed with the SEC on June 6, 2025 — read the filing on EDGAR.
See voting trends for Industrials companies, 2024-2025: shareholder support by sector and by company size.
215 asset managers disclosed a vote on at least one PACIFIC BIOSCIENCES OF CALIFORNIA INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Christopher M. Smith
PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Elect Director: Christopher M. Smith”): 126,830,161 for, 2,076,866 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The four matters voted on at the Annual Meeting and the voting results with respect to each such matter are set forth below: Proposal 1: Election of Four Class III Directors Each director nominee was duly elected to serve until the 2026 annual meeting of stockholders and until his or her successor …”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 43 asset managers below reported 6,286,883 for, 119,722 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,598,492 | 0 | 0 | 0 | For |
| T. Rowe Price | 879,921 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 758,277 | 0 | 0 | 0 | For |
| Lincoln Financial | 390,504 | 0 | 0 | 0 | For |
| Fidelity | 344,449 | 0 | 0 | 0 | For |
| BlackRock | 284,215 | 0 | 0 | 0 | For |
| Equitable | 265,211 | 0 | 0 | 0 | For |
| Charles Schwab | 227,135 | 0 | 0 | 0 | For |
| ARK Venture Fund | 197,136 | 0 | 0 | 0 | For |
| Northern Trust | 173,768 | 0 | 0 | 0 | For |
| Pacific Life | 138,093 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 134,010 | 0 | 0 | 0 | For |
| Global X | 127,394 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 123,029 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 0 | 119,722 | 0 | 0 | Against |
| Goldman Sachs | 105,644 | 0 | 0 | 0 | For |
| Gabelli | 100,000 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 89,097 | 0 | 0 | 0 | For |
| SEI | 46,800 | 0 | 0 | 0 | For |
| Invesco | 45,184 | 0 | 0 | 0 | For |
| DWS | 42,401 | 0 | 0 | 0 | For |
| ProShares | 40,477 | 0 | 0 | 0 | For |
| State Street | 34,832 | 0 | 0 | 0 | For |
| Nationwide | 27,748 | 0 | 0 | 0 | For |
| Calvert | 26,094 | 0 | 0 | 0 | For |
Showing the 25 largest of 43 asset managers. All 43 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Kathy Ordonez
PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Elect Director: Kathy Ordoñez”): 126,729,273 for, 2,137,971 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The four matters voted on at the Annual Meeting and the voting results with respect to each such matter are set forth below: Proposal 1: Election of Four Class III Directors Each director nominee was duly elected to serve until the 2026 annual meeting of stockholders and until his or her successor …”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 43 asset managers below reported 6,239,047 for, 167,558 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,598,492 | 0 | 0 | 0 | For |
| T. Rowe Price | 879,921 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 758,277 | 0 | 0 | 0 | For |
| Lincoln Financial | 375,237 | 15,267 | 0 | 0 | For |
| Fidelity | 344,449 | 0 | 0 | 0 | For |
| BlackRock | 284,215 | 0 | 0 | 0 | For |
| Equitable | 265,211 | 0 | 0 | 0 | For |
| Charles Schwab | 227,135 | 0 | 0 | 0 | For |
| ARK Venture Fund | 197,136 | 0 | 0 | 0 | For |
| Northern Trust | 173,768 | 0 | 0 | 0 | For |
| Pacific Life | 138,093 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 134,010 | 0 | 0 | 0 | For |
| Global X | 127,394 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 123,029 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 0 | 119,722 | 0 | 0 | Against |
| Goldman Sachs | 105,644 | 0 | 0 | 0 | For |
| Gabelli | 100,000 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 89,097 | 0 | 0 | 0 | For |
| SEI | 46,800 | 0 | 0 | 0 | For |
| Invesco | 45,184 | 0 | 0 | 0 | For |
| DWS | 42,401 | 0 | 0 | 0 | For |
| ProShares | 40,477 | 0 | 0 | 0 | For |
| State Street | 34,832 | 0 | 0 | 0 | For |
| Nationwide | 27,748 | 0 | 0 | 0 | For |
| Calvert | 26,094 | 0 | 0 | 0 | For |
Showing the 25 largest of 43 asset managers. All 43 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
81% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: William Ericson
PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Elect Director: William Ericson”): 104,132,466 for, 24,793,642 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The four matters voted on at the Annual Meeting and the voting results with respect to each such matter are set forth below: Proposal 1: Election of Four Class III Directors Each director nominee was duly elected to serve until the 2026 annual meeting of stockholders and until his or her successor …”
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 43 asset managers below reported 5,486,995 for, 919,610 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,598,492 | 0 | 0 | 0 | For |
| T. Rowe Price | 879,921 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 758,277 | 0 | 0 | 0 | For |
| Lincoln Financial | 375,237 | 15,267 | 0 | 0 | For |
| Fidelity | 239,027 | 105,422 | 0 | 0 | Mixed |
| BlackRock | 0 | 284,215 | 0 | 0 | Against |
| Equitable | 217,760 | 47,451 | 0 | 0 | Mixed |
| Charles Schwab | 227,135 | 0 | 0 | 0 | For |
| ARK Venture Fund | 197,136 | 0 | 0 | 0 | For |
| Northern Trust | 173,768 | 0 | 0 | 0 | For |
| Pacific Life | 0 | 138,093 | 0 | 0 | Against |
| AIG/SunAmerica | 134,010 | 0 | 0 | 0 | For |
| Global X | 127,394 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 123,029 | 0 | 0 | Against |
| Investment Managers Series Trust II | 0 | 119,722 | 0 | 0 | Against |
| Goldman Sachs | 105,644 | 0 | 0 | 0 | For |
| Gabelli | 100,000 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 89,097 | 0 | 0 | 0 | For |
| SEI | 46,800 | 0 | 0 | 0 | For |
| Invesco | 45,184 | 0 | 0 | 0 | For |
| DWS | 42,401 | 0 | 0 | 0 | For |
| ProShares | 40,477 | 0 | 0 | 0 | For |
| State Street | 34,832 | 0 | 0 | 0 | For |
| Nationwide | 0 | 27,748 | 0 | 0 | Against |
| Calvert | 0 | 26,094 | 0 | 0 | Against |
Showing the 25 largest of 43 asset managers. All 43 are in the interactive database (link above).
66% Approved · of votes cast
Prior year: 74.3% for (June 18, 2024 meeting) ▼ 8.1 pts
Description as filed by funds: TO APPROVE THE AMENDMENT OF OUR 2020 EQUITY INCENTIVE PLAN.
PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“4. Approval of Amendment to the 2020 Equity Incentive Plan”): 85,355,382 for, 43,563,859 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 4: Approval of Amendment to the 2020 Equity Incentive Plan”
Support: 66% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 44 asset managers below reported 4,179,563 for, 2,229,148 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,598,492 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 879,921 | 0 | 0 | Against |
| Managed Portfolio Series | 0 | 758,277 | 0 | 0 | Against |
| Lincoln Financial | 199,398 | 191,106 | 0 | 0 | Mixed |
| Fidelity | 344,449 | 0 | 0 | 0 | For |
| BlackRock | 284,215 | 0 | 0 | 0 | For |
| Equitable | 265,211 | 0 | 0 | 0 | For |
| Charles Schwab | 227,135 | 0 | 0 | 0 | For |
| ARK Venture Fund | 197,136 | 0 | 0 | 0 | For |
| Northern Trust | 173,768 | 0 | 0 | 0 | For |
| Pacific Life | 138,093 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 134,010 | 0 | 0 | Against |
| Global X | 127,394 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 123,029 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 119,722 | 0 | 0 | 0 | For |
| Goldman Sachs | 105,644 | 0 | 0 | 0 | For |
| Gabelli | 0 | 100,000 | 0 | 0 | Against |
| AMERICAN BEACON FUNDS | 89,097 | 0 | 0 | 0 | For |
| SEI | 46,800 | 0 | 0 | 0 | For |
| Invesco | 45,184 | 0 | 0 | 0 | For |
| DWS | 0 | 42,401 | 0 | 0 | Against |
| ProShares | 0 | 40,477 | 0 | 0 | Against |
| State Street | 34,832 | 0 | 0 | 0 | For |
| Nationwide | 27,748 | 0 | 0 | 0 | For |
| Calvert | 0 | 26,094 | 0 | 0 | Against |
Showing the 25 largest of 44 asset managers. All 44 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
61% Approved · of votes cast
Prior year: 95.8% for (June 18, 2024 meeting) ▼ 35.0 pts
Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers.
PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“3. Advisory Vote on Approval of Named Executive Officer Compensation”): 78,367,531 for, 50,498,020 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers.”
Support: 61% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,598,492 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 879,921 | 0 | 0 | Against |
| Managed Portfolio Series | 0 | 758,277 | 0 | 0 | Against |
| Lincoln Financial | 199,398 | 191,106 | 0 | 0 | Mixed |
| Fidelity | 239,027 | 105,422 | 0 | 0 | Mixed |
| BlackRock | 0 | 284,215 | 0 | 0 | Against |
| Equitable | 217,760 | 47,451 | 0 | 0 | Mixed |
| Charles Schwab | 0 | 227,135 | 0 | 0 | Against |
| ARK Venture Fund | 197,136 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 173,768 | 0 | 0 | Against |
| Pacific Life | 0 | 138,093 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 134,010 | 0 | 0 | Against |
| Global X | 0 | 127,394 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 123,029 | 0 | 0 | Against |
| Investment Managers Series Trust II | 0 | 119,722 | 0 | 0 | Against |
| Goldman Sachs | 0 | 105,644 | 0 | 0 | Against |
| Gabelli | 100,000 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 89,097 | 0 | 0 | 0 | For |
| SEI | 0 | 46,800 | 0 | 0 | Against |
| Invesco | 0 | 45,184 | 0 | 0 | Against |
| DWS | 0 | 42,401 | 0 | 0 | Against |
| ProShares | 0 | 40,477 | 0 | 0 | Against |
| State Street | 34,832 | 0 | 0 | 0 | For |
| Nationwide | 0 | 27,748 | 0 | 0 | Against |
| Calvert | 0 | 26,094 | 0 | 0 | Against |
Fund voting reports, all 43 managers: 2,683,940 for, 3,722,665 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Madrone Advisors, LLC | 20,941,915 | 0 | 0 | 0 | For |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 0 | 20,208,780 | 0 | 0 | Against |
| Nikko Asset Management Co., Ltd. | 0 | 9,565,331 | 0 | 0 | Against |
| State Street | 3,831,906 | 52,091 | 0 | 0 | For |
| BlackRock | 405,548 | 1,465,225 | 0 | 0 | Mixed |
| Jackson Square Partners, LLC | 0 | 1,518,068 | 0 | 0 | Against |
| Northern Trust | 0 | 1,259,144 | 0 | 0 | Against |
| T. Rowe Price | 0 | 1,208,167 | 0 | 0 | Against |
| ARK Investment Management LLC | 989,766 | 0 | 0 | 0 | For |
| NORDEA INVESTMENT MANAGEMENT AB | 0 | 955,349 | 0 | 0 | Against |
| HHLR ADVISORS, LTD. | 918,892 | 0 | 0 | 0 | For |
| BOURNE LENT ASSET MANAGEMENT INC | 857,855 | 0 | 0 | 0 | For |
| Casdin Capital, LLC | 0 | 723,767 | 0 | 0 | Against |
| Vestmark Advisory Solutions, Inc. | 0 | 659,750 | 0 | 0 | Against |
| Mirador Capital Partners LP | 0 | 0 | 508,795 | 0 | Abstain |
| MELLON INVESTMENTS Corp | 0 | 496,672 | 0 | 0 | Against |
| ArrowMark Colorado Holdings LLC | 0 | 468,382 | 0 | 0 | Against |
| Universal-Investment-Gesellschaft mbH | 0 | 408,700 | 0 | 0 | Against |
| Two Sigma | 0 | 304,430 | 0 | 0 | Against |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 0 | 300,406 | 0 | 0 | Against |
| Senvest Management, LLC | 0 | 288,879 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 255,616 | 0 | 0 | 0 | For |
| UBS | 0 | 239,375 | 0 | 0 | Against |
| Charles Schwab | 0 | 227,152 | 0 | 0 | Against |
| AllianceBernstein | 217,760 | 0 | 0 | 0 | For |
Institutional-manager reports, all 186 managers: 29,059,560 for, 42,880,150 against, 509,295 abstained, 3,438 not voted. Showing the 25 largest; every one is in the interactive database (link above).
88% Approved · of votes cast
Prior year: 98.9% for (June 18, 2024 meeting) ▼ 11.1 pts
Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2025.
PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“2. Ratification of the Appointment of Independent Registered Public Accounting Firm”): 162,154,849 for, 22,599,739 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 43 asset managers below reported 6,406,605 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,598,492 | 0 | 0 | 0 | For |
| T. Rowe Price | 879,921 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 758,277 | 0 | 0 | 0 | For |
| Lincoln Financial | 390,504 | 0 | 0 | 0 | For |
| Fidelity | 344,449 | 0 | 0 | 0 | For |
| BlackRock | 284,215 | 0 | 0 | 0 | For |
| Equitable | 265,211 | 0 | 0 | 0 | For |
| Charles Schwab | 227,135 | 0 | 0 | 0 | For |
| ARK Venture Fund | 197,136 | 0 | 0 | 0 | For |
| Northern Trust | 173,768 | 0 | 0 | 0 | For |
| Pacific Life | 138,093 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 134,010 | 0 | 0 | 0 | For |
| Global X | 127,394 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 123,029 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 119,722 | 0 | 0 | 0 | For |
| Goldman Sachs | 105,644 | 0 | 0 | 0 | For |
| Gabelli | 100,000 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 89,097 | 0 | 0 | 0 | For |
| SEI | 46,800 | 0 | 0 | 0 | For |
| Invesco | 45,184 | 0 | 0 | 0 | For |
| DWS | 42,401 | 0 | 0 | 0 | For |
| ProShares | 40,477 | 0 | 0 | 0 | For |
| State Street | 34,832 | 0 | 0 | 0 | For |
| Nationwide | 27,748 | 0 | 0 | 0 | For |
| Calvert | 26,094 | 0 | 0 | 0 | For |
Showing the 25 largest of 43 asset managers. All 43 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 300,041,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 0.53% |
| 2 | T. Rowe Price | 0.29% |
| 3 | Managed Portfolio Series | 0.25% |
| 4 | Lincoln Financial | 0.13% |
| 5 | Fidelity | 0.11% |
| 6 | BlackRock | 0.09% |
| 7 | Equitable | 0.09% |
| 8 | Charles Schwab | 0.08% |
| 9 | ARK Venture Fund | 0.07% |
| 10 | Northern Trust | 0.06% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Madrone Advisors, LLC | 6.98% |
| 2 | EDMOND DE ROTHSCHILD HOLDING S.A. | 6.74% |
| 3 | Nikko Asset Management Co., Ltd. | 3.19% |
| 4 | State Street | 1.29% |
| 5 | BlackRock | 0.62% |
| 6 | Jackson Square Partners, LLC | 0.51% |
| 7 | Northern Trust | 0.42% |
| 8 | T. Rowe Price | 0.40% |
| 9 | ARK Investment Management LLC | 0.33% |
| 10 | NORDEA INVESTMENT MANAGEMENT AB | 0.32% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| ARK Investment Management LLC | 37,264,228 | 12.42% | Schedule 13G, filed February 3, 2026 |
| Madrone Opportunity Fund, L.P. | 26,891,915 | 8.96% | Proxy statement (DEF 14A), proxy filed April 23, 2025 |
| BlackRock | 23,455,252 | 7.82% | Form 13F, quarter ended March 31, 2025 |
| SB Northstar LP | 20,451,570 | 6.82% | Proxy statement (DEF 14A), proxy filed April 23, 2025 |
| Vanguard Group | 16,263,464 | 5.42% | Form 13F, quarter ended March 31, 2025 |
| EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) | 13,366,200 | 4.45% | Schedule 13G, filed July 24, 2025 |
| Gregory Boyd Penner | 8,476,089 | 2.82% | Schedule 13G, filed November 14, 2025 |
| State Street | 6,379,592 | 2.13% | Form 13F, quarter ended March 31, 2025 |
| Geode Capital | 6,317,242 | 2.11% | Form 13F, quarter ended March 31, 2025 |
| Morgan Stanley | 3,371,732 | 1.12% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 300,041,000 shares outstanding, as reported by PACIFIC BIOSCIENCES OF CALIFORNIA INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At PACIFIC BIOSCIENCES OF CALIFORNIA INC.'s shareholder meeting held June 4, 2025, in the 2024-2025 proxy season, 215 asset managers reported votes on at least one of its 6 ballot items in their SEC Form N-PX filings, covering 916 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers. — PACIFIC BIOSCIENCES OF CALIFORNIA INC.'s filing reports the proposal as approved, with 61% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: PACIFIC BIOSCIENCES OF CALIFORNIA INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 6, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
PACIFIC BIOSCIENCES OF CALIFORNIA INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “PACIFIC BIOSCIENCES OF CALIFORNIA (PACB) 2025 Annual Meeting”, https://proxyvotesnow.com/company/pacific-biosciences-of-california-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.